InDevR Introduces Latest Solution for Influenza Vaccine Manufacturers, OmniFlu HA, to Simplify Vaccine Testing and Speed Time to Market
Validated, off-the-shelf kit for multiplexed seasonal hemagglutinin (HA) detection and quantification addresses the unique challenges faced by vaccine developers and manufacturers. BOULDER, Colo., May 22,